新天药业：目前正按计划推进创新药研发进度

Core Viewpoint - The company is advancing its innovative drug development as planned, with a focus on a new treatment for cancer-related fatigue [1] Group 1: Drug Development Progress - The company has received approval from the drug regulatory authority for clinical trials of its Xinlikang capsules, aimed at treating cancer-related fatigue, which is a significant milestone in its research efforts [1]